bioRxivCancer BiologyPreprint
NF1 deficiency induces metabolic reprogramming and epithelial-mesenchymal transition in glioblastoma
Qiang Dong, Jing Shi, Hang Yin, B WangiD, Liang NiuiD, X WangiD, Junqing Dai, Qi LiiD, Yawen PaniD, Guoqiang YuaniD
Abstract
BackgroundMetabolic reprogramming is a common occurrence in tumor cells, where enhanced glycolysis promotes cell growth, invasion and migration. NF1 is tumor suppressor gene that downregulates the encoded neurofibromin protein. However, the effects of NF1 on energy metabolism and epithelial-mesenchymal transition (EMT) in glioblastoma multiforme (GBM), as well as the underlying molecular mechanisms, remain unclear. MethodsCRISPR/Cas9 gene editing technology was employed to construct GBM cell lines with NF1 gene mutations. Metabolomics was utilized to examine the impact of NF1 on metabolic remodeling in GBM. The Seahorse XF24 extracellular flux analyzer was used to detect the effect of NF1 knockdown on glycolysis and mitochondrial oxidative phosphorylation in GBM cells. Wound healing assay and Transwell chamber assay were utilized to detect the effect of NF1 on GBM cell invasion. Orthotopic tumor model in nude mice was established to explore the role of NF1 in vivo. In addition, Co-IP, western blotting, and immunofluorescence were used to explore the changes of key enzymes in glycolysis and mitochondrial oxidative phosphorylation and the relationship between NF1 and MFN1. ResultsThe expression of NF1 is decreased in glioma tissues and is significantly correlated with patient prognosis. NF1 knockdown may promote the invasion, migration, and EMT of GBM cells. At the same time, the activation of the AKT/mTOR signaling pathway promotes aerobic glycolysis in GBM cells, promotes mitochondrial division through targeted regulation of MFN1, and inhibits mitochondrial oxidative phosphorylation. NF1 deficiency promotes EMT in GBM cells by enhancing aerobic glycolysis and mitochondrial division. ConclusionNF1 deficiency promotes GBM glycolysis by activating the AKT/mTOR signaling pathway and inhibits the mitochondrial oxidative phosphorylation by regulating MFN1; NF1 deletion promotes GBM EMT by remodeling the pattern of energy metabolism.
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
C. Marques, T. Unterkircher, … M. Squatrito·bioRxiv·Nov 6, 2020
- MEK inhibition enhances the antitumor effect of radiation therapy in NF1-deficient glioblastoma
M. Ioannou, K. Lalwani, … K. C. Schreck·bioRxiv·Aug 4, 2023
- FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation
Roza H. Ali Masalmeh, John C. Dawson, … Margaret C. Frame·Disease Models & MechanismsPeer-reviewed·Sep 22, 2025
- Glucose starvation to rapid death of Nrf1, but not Nrf2, deficient hepatoma cells from its fatal defects in the redox metabolism reprogramming
- MAT2a and AHCY Inhibition Disrupts Antioxidant Metabolism and Reduces Glioblastoma Cell Survival
Emma C. Rowland, Matthew D’Antuono, … Nagi G. Ayad·Journal of Biological ChemistryPeer-reviewed·Feb 25, 2025
- Multiplatform molecular profiling and functional genomic screens identify prognostic signatures and mechanisms underlying MEK inhibitor response in somatic NF1 mutant glioblastoma
Sixuan Pan, Kanish Mirchia, … Harish N. Vasudevan·bioRxiv·Jul 1, 2024